MAUDE Adverse Event Report: STRYKER NEUROVASCULAR CORK EXCELSIOR XT-27 STD PRE-SHAPED 150CM; CATHETER, PERCUTANEOUS

Catalog Number	M003XT2750910
Medical Device Problem Code	Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Codes	Visual Disturbances (2140); Ischemia Stroke (4418)
Date of Event	12/09/2025
Type of Reportable Event	Serious Injury
Additional Manufacturer Narrative
This is 3 of 3 reports.
Event or Problem Description
It was reported that the initial procedure of the stent implantation was conducted on (b)(6) 2025 as the patient had no limb hemiplegia or aphasia and cranial after surgery.After the procedure, the diagnostic imaging and mri (magnetic resonance imaging) showed two acute lacunar infarction foci in the left subcortex senile cerebral changes left maxillary sinusitis: mild right mastoid inflammation postoperative changes of the left ocular lens.The event was considered as an ischemic stroke located at ipsilateral and it was treated with medication.One day post procedure on (b)(6) 2025, the patient developed binocular diplopia as it was resolved on (b)(6) 2025.The patient received intravenous infusion of human albumin for volume expansion.Later, a new lacunar cerebral infarction was detected by mri, and edaravone dexborneol was administered to scavenge free radicals.In physician¿s opinion, the cause of the stroke and binocular diplopia as the stent implantation covers the ophthalmic artery, causing a thrombogenic reaction that affects the blood supply of the central retinal artery and probably also related to the catheter (subject device).Currently, there is no impairment in daily life and work to the patient.
Additional Manufacturer Narrative
D4 expiration date ¿ added, d4 gtin- added, h4 manufacturing date ¿ added.Due to the automated manufacturing execution system (mes) system there are controls in the manufacturing process to ensure the product met specifications upon release.The subject device was not available; therefore, a visual inspection as well as a functional evaluation could not be performed.The reported complaint could not be confirmed, and it could not be definitively determined if the device failed to meet specifications because the product was not returned.The reported event is covered in the device directions for use (dfu).As well, the risk of the reported event is documented in the risk documentation and there are current controls to mitigate the risk of the as reported event.Additional information received indicated the patient had no limb hemiplegia or aphasia after surgery, and cranial mri showed a new lacunar infarction in the left frontal lobe.Event occurred post-procedure.Two acute lacunar infarction foci in the left subcortex senile cerebral changes left maxillary sinusitis; mild right mastoid inflammation postoperative changes of the left ocular lens.On the first day after surgery, the patient complained of binocular diplopia.The patient received intravenous infusion of human albumin for volume expansion.Later, a new lacunar cerebral infarction was detected by mri, and edaravone dexborneol was administered to scavenge free radicals.An assignable cause of anticipated procedural complication will be assigned to the reported ¿patient stroke' and 'patient complications¿ as a product related root cause does not apply and the issue is due to a known physiological effect of the procedure and/or patient condition noted with the directions for use, product labelling and/or risk documentation files.
Event or Problem Description
It was reported that the initial procedure of the stent implantation was conducted on (b)(6) 2025 as the patient had no limb hemiplegia or aphasia and cranial after surgery.After the procedure, the diagnostic imaging and mri (magnetic resonance imaging) showed two acute lacunar infarction foci in the left subcortex senile cerebral changes left maxillary sinusitis: mild right mastoid inflammation postoperative changes of the left ocular lens.The event was considered as an ischemic stroke located at ipsilateral and it was treated with medication.One day post procedure on (b)(6) 2025, the patient developed binocular diplopia as it was resolved on (b)(6) 2025.The patient received intravenous infusion of human albumin for volume expansion.Later, a new lacunar cerebral infarction was detected by mri, and edaravone dexborneol was administered to scavenge free radicals.In physician¿s opinion, the cause of the stroke and binocular diplopia as the stent implantation covers the ophthalmic artery, causing a thrombogenic reaction that affects the blood supply of the central retinal artery and probably also related to the catheter (subject device).Currently, there is no impairment in daily life and work to the patient.
Event or Problem Description
It was reported that the initial procedure of the stent implantation was conducted on (b)(6) 2025 as the patient had no limb hemiplegia or aphasia and cranial after surgery.After the procedure, the diagnostic imaging and mri (magnetic resonance imaging) showed two acute lacunar infarction foci in the left subcortex senile cerebral changes left maxillary sinusitis: mild right mastoid inflammation postoperative changes of the left ocular lens.The event was considered as an ischemic stroke located at ipsilateral and it was treated with medication.One day post procedure on (b)(6) 2025, the patient developed binocular diplopia as it was resolved on (b)(6) 2025.The patient received intravenous infusion of human albumin for volume expansion.Later, a new lacunar cerebral infarction was detected by mri, and edaravone dexborneol was administered to scavenge free radicals.In physician¿s opinion, the cause of the stroke and binocular diplopia as the stent implantation covers the ophthalmic artery, causing a thrombogenic reaction that affects the blood supply of the central retinal artery and probably also related to the catheter (subject device).Currently, there is no impairment in daily life and work to the patient.Update: received an update from safety on 31-mar-2026 stated there¿s no adverse event 'diplopia' occurred post procedure as the patient just had lacunar infarction.
Additional Manufacturer Narrative
B5 executive summary- update - received an update from safety on 31-mar-2026 stated there¿s no adverse event 'diplopia' occurred post procedure as the patient just had lacunar infarction.F10 & h6 health impact code grid- corrected - no ¿visual disturbance¿.Due to the automated manufacturing execution system (mes) system there are controls in the manufacturing process to ensure the product met specifications upon release.The subject device was not available; therefore, a visual inspection as well as a functional evaluation could not be performed.The reported complaint could not be confirmed, and it could not be definitively determined if the device failed to meet specifications because the product was not returned.The reported event is covered in the device directions for use (dfu).As well, the risk of the reported event is documented in the risk documentation and there are current controls to mitigate the risk of the as reported event.Additional information provided by the customer indicated the current condition of the patient was no impairment in daily life and work.In physician¿s opinion, the cause of the stroke was the stent covers the ophthalmic artery, causing a thrombogenic reaction that affects the blood supply of the central retinal artery.The patient received intravenous infusion of human albumin for volume expansion as a result of this stroke.Later, a new lacunar cerebral infarction was detected by mri, and edaravone dexborneol was administered to scavenge free radicals.Based upon medical review, the harm observed in this complaint is anticipated in nature as per the device risk assessment.An assignable cause of anticipated procedural complication will be assigned to the reported ¿patient stroke' as a product related root cause does not apply and the issue is due to a known physiological effect of the procedure and/or patient condition noted with the directions for use, product labelling and/or risk documentation files.

• Brand Name: EXCELSIOR XT-27 STD PRE-SHAPED 150CM
• Common Device Name: CATHETER, PERCUTANEOUS
• Manufacturer (Section D): STRYKER NEUROVASCULAR CORK; ida industrial estate; model farm road; cork NA ; EI NA
• Manufacturer (Section G): STRYKER NEUROVASCULAR CORK; ida industrial estate; model farm road; cork NA ; EI NA
• Manufacturer Contact: tara lopez ; 47900 bayside parkway; fremont, CA 94538 ; 5104132500
• MDR Report Key: 24060000
• Report Number: 3008881809-2026-00017
• Device Sequence Number: 9421874
• Product Code: DQY
• UDI-Device Identifier: 04546540698155
• UDI-Public: (01)04546540698155(17)280608(10)25652018
• Combination Product (Y/N): N
• Initial Reporter Country: CH
• PMA/510(K) Number: K113778
• Number of Events Summarized: 1
• Summary Report (Y/N): N
• Device Implanted Year: 2025
• Reporter Type: Manufacturer
• Report Source: Health Professional
• Initial Reporter Occupation: Physician
• Type of Report: Initial,Followup,Followup
• Report Date (Section B): 04/17/2026

1 Device was Involved in the Event

1 Patient was Involved in the Event

• Is this an Adverse Event Report?: Yes
• Is this a Product Problem Report?: No
• Operator of Device: Health Professional
• Device Catalogue Number: M003XT2750910
• Device Lot Number: 25652018
• Was Device Available for Evaluation?: No
• Is the Reporter a Health Professional?: Yes
• Type of Report(Section G): Initial
• Initial Date Received by Manufacturer: 12/19/2025
• Supplement Date Received by Manufacturer: 02/26/2026; 03/31/2026
• Initial Report FDA Received Date: 01/13/2026
• Supplement Report FDA Received Date: 03/18/2026; 04/17/2026
• Was Device Evaluated by Manufacturer? (Y/N): No
• Date Device Manufactured: 06/10/2025
• Is the Device Labeled for Single Use? (Y/N): Yes
• Is This a Single-Use Device that was Reprocessed and Reused on a Patient? (Y/N): No
• Usage of Device: Initial
• Patient Sequence Number: 1
• Concomitant Medical Products and Therapy/Usage Dates: SYNCHRO GUIDEWIRE (STRYKER).
• Outcome Attributed to Adverse Event: Other; Required Intervention
• Patient Age: 69 YR
• Patient Sex: Female